Published in J Infect on July 01, 1986
Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis (2000) 1.82
Parvovirus b19 infection in pediatric patients with hematological disorders. J Glob Infect Dis (2013) 0.78
Acute anaemia and aplastic crisis without haemolysis in human parvovirus infection. J Clin Pathol (1987) 0.75
Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med (1999) 4.79
Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry (2002) 3.41
Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology (2006) 2.90
Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who are non-responders to hepatitis B vaccine. Lancet (1994) 2.78
Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke (2000) 2.59
HTLV-I/II antibodies in French blood donors. Lancet (1990) 2.54
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology (2007) 2.52
Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology (1991) 2.38
Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg (2000) 2.25
Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy. Clin Exp Allergy (2008) 2.15
Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry (2005) 2.08
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol (2004) 1.97
Pallidal stimulation for Parkinson's disease. Two targets? Neurology (1997) 1.69
Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry (2005) 1.60
Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD. Neurology (2000) 1.55
Brainstem gliomas in adults: prognostic factors and classification. Brain (2001) 1.46
Polymerase chain reaction testing of HIV-1 seronegative at-risk individuals. Lancet (1990) 1.46
Prevalence of hepatitis G virus RNA in French blood donors and recipients. Transfusion (1997) 1.42
[Cerebral tropical malaria with blackwater fever. A current diagnostic and therapeutic problem]. Schweiz Med Wochenschr (1974) 1.41
Amoxycillin/clavulanic acid prophylaxis in elective colorectal surgery: a prospective randomized trial. J Hosp Infect (1997) 1.39
Human T-cell lymphotropic virus type I and II DNA amplification in seropositive and seronegative at-risk individuals. Transfusion (1993) 1.38
Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain (2002) 1.38
Acute cardiovascular collapse during intravenous vitamin K1 injection. Thromb Haemost (1987) 1.38
Correspondence between functional magnetic resonance imaging somatotopy and individual brain anatomy of the central region: comparison with intraoperative stimulation in patients with brain tumors. J Neurosurg (2000) 1.35
Six cases of hereditary spherocytosis revealed by human parvovirus infection. Br J Haematol (1986) 1.30
Aggressive behavior induced by intraoperative stimulation in the triangle of Sano. Neurology (2002) 1.27
A new method to assay des-gamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma. Gastroenterology (1986) 1.27
Autoimmune haemolytic anaemia revealed by human parvovirus linked erythroblastopenia. Lancet (1985) 1.26
Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry (2000) 1.21
EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol (2006) 1.17
PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. J Nucl Med (1991) 1.17
Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation. Br Med J (Clin Res Ed) (1981) 1.16
Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP. J Viral Hepat (1999) 1.16
Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol (2000) 1.15
Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology (2004) 1.14
Fetal hemoglobin in sudden infant death syndrome. N Engl J Med (1989) 1.10
Prevention of virus B hepatitis (SH hepatitis). Am J Dis Child (1972) 1.09
Human parvovirus infections in France. Lancet (1984) 1.09
Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma. J Infect Dis (1992) 1.08
Erythroid hypoplasia due to chronic infection with parvovirus B19. N Engl J Med (1990) 1.07
[Painful disseminated fibromatosis (systemic hyalinosis): a new hereditary collagen dysplasia]. Arch Fr Pediatr (1978) 1.07
Evaluation of eight ELISA kits for the detection of anti-LAV/HTLV-III antibodies. Lancet (1986) 1.07
Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease. J Neurophysiol (2007) 1.07
Functional mapping of the human globus pallidus: contrasting effect of stimulation in the internal and external pallidum in Parkinson's disease. Neuroscience (2000) 1.07
Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis (1998) 1.07
Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease. J Pediatr Hematol Oncol (1997) 1.06
Role of the supplementary motor area in motor deficit following medial frontal lobe surgery. Neurology (2001) 1.06
Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.05
Long-lasting abatement of HBsAg synthesis induced by acute delta infection. Lancet (1983) 1.05
Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet (1994) 1.04
Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease. Blood (1998) 1.04
Full or partial seroreversion in patients infected by hepatitis C virus. J Infect Dis (1997) 1.03
Gadolinium-DOTA enhanced MRI of painful osseous crises in children with sickle cell anemia. Pediatr Radiol (1994) 1.03
Postoperative speech disorder after medial frontal surgery: role of the supplementary motor area. Neurology (2003) 1.01
Sickle cell leg ulcers: a frequently disabling complication and a marker of severity. Br J Dermatol (2007) 1.01
Role of the healthy hemisphere in recovery after resection of the supplementary motor area. Neurology (2004) 1.01
Four new haplotypes observed in Algerian beta-thalassemia patients. Hum Genet (1983) 0.99
Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: evidence of sexual and parenteral transmission. Transfusion (1999) 0.98
A special form of cerebral lacunae: expanding lacunae. J Neurol Neurosurg Psychiatry (1996) 0.98
DNA amplification of HIV-1 in seropositive individuals and in seronegative at-risk individuals. AIDS (1990) 0.97
Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. Eur J Haematol (2000) 0.97
Radiosurgery for re-irradiation of brain metastasis: results in 54 patients. Radiother Oncol (2001) 0.97
Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease. Arch Dermatol (2001) 0.96
Fetal haemoglobin variations following hydroxyurea treatment in patients with cyanotic congenital heart disease. Nouv Rev Fr Hematol (1994) 0.96
Use of HBV vaccine in hemophiliacs. Scand J Haematol Suppl (1984) 0.95
Transmission of HIV by blood from seronegative donors. Lancet (1988) 0.95
Hepatitis B virus multiplication in the absence of usual serological markers. A study of 146 chronic alcoholics. J Hepatol (1985) 0.94
Sensitivity of screening kits for anti-HIV-1 subtype O antibodies. AIDS (1994) 0.94
Irregular jerky tremor, myoclonus, and thalamus: a study using low-frequency stimulation. Mov Disord (2000) 0.93
Monoclonal gammopathies in asymptomatic HIV-seropositive patients. Clin Chem (1987) 0.93
Human parvovirus and rheumatoid arthritis. Lancet (1985) 0.93
[Prevention of sickle cell crises with multiple phlebotomies]. Arch Pediatr (2000) 0.93
Biology of meningiomas. Acta Neurochir (Wien) (2000) 0.92
Natural history of the TT virus infection through follow-up of TTV DNA-positive multiple-transfused patients. Blood (2000) 0.92
Morphology of demyelination in the human central nervous system. J Neuroimmunol (1992) 0.92
An epidemiological and clinical study of transaminase levels and hepatitis B antibodies in 1,100 blood donors. Vox Sang (1989) 0.92
Timing of hepatitis B revaccination in healthy adults. Lancet (1987) 0.91
Calcium phosphate metabolism and bone disease in patients with homozygous thalassemia. J Clin Endocrinol Metab (1982) 0.91
[Castleman disease: 2 unusual cases]. Schweiz Med Wochenschr (1998) 0.91
Peripheral blood cells from patients wih aplastic anaemia in partial remission suppress growth of their own bone marrow precursors in culture. Br J Haematol (1980) 0.90
[Ependymoma of the intradural filum terminale in adults. 20 cases]. Neurochirurgie (1990) 0.90
Partial splenectomy in homozygous beta thalassaemia. Arch Dis Child (1990) 0.89
Parvovirus B19 infection during acute Plasmodium falciparum malaria. Eur J Haematol (1992) 0.89
[Loaiasis with high microfilaremia. Attempted extracorporal purification after exsanguination-transfusion]. Bull Soc Pathol Exot Filiales (1971) 0.89
Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia. Exp Hematol (1976) 0.89
Hepatitis B vaccination in chronic alcoholics. J Hepatol (1986) 0.89
[Parvovirus B 19]. Presse Med (1986) 0.89
Prognostic factors and evolution of acquired aplastic anemia in childhood. A prospective analysis of 48 androgen-treated cases. Am J Pediatr Hematol Oncol (1982) 0.89
Chronic thalamic stimulation with three-dimensional MR stereotactic guidance. AJNR Am J Neuroradiol (1997) 0.89
Non-radioactive hepatitis B virus DNA probe for detection of HBV-DNA in serum. J Hepatol (1987) 0.89